The CHMP opinion is based on the efficacy and safety demonstrated in the Phase 3 RELAY trial – a global randomized, double-blind, placebo-controlled trial evaluating CYRAMZA in combination with ...
"There is no cure for people with metastatic EGFR-mutated lung cancer and, despite recent advancements, there remains an unmet need for additional first-line therapeutic options and new treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback